Figure 6

Top enriched IPA disease pathways. Top diseases in the amygdala after CMC treatment (a) or P80 treatment (b) and PVN after CMC treatment (c) or P80 treatment (d). Threshold indicates minimum significance level [–log (p-value) from Fisher’s exact test].